6-K/A XBRL

6-K/A

Company: Galmed Pharmaceuticals Ltd.
Filed: June 23, 2017
Period of Report: June 23, 2017
Accession Number: 0001144204-17-033829

View Document ↗ View on SEC.gov ↗